PART I Financial Information [Financial Statements](index=5&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited consolidated financial statements for Omega and its operating partnership for Q3 2019 [Financial Statements of Omega Healthcare Investors, Inc.](index=5&type=section&id=Financial%20Statements%20of%20Omega%20Healthcare%20Investors%2C%20Inc.) Details the company's key financial performance and balance sheet highlights for the third quarter and first nine months of 2019 Omega Healthcare Investors, Inc. - Key Financial Data (in thousands) | Financial Metric | Q3 2019 | Q3 2018 | 9 Months 2019 | 9 Months 2018 | | :--- | :--- | :--- | :--- | :--- | | **Total Operating Revenues** | $233,195 | $221,852 | $682,162 | $661,932 | | **Operating Income** | $187,160 | $110,672 | $435,860 | $381,484 | | **Net Income** | $142,948 | $59,062 | $290,801 | $228,981 | | **Net Income Available to Common Stockholders** | $138,740 | $56,606 | $281,583 | $219,362 | | **Diluted EPS** | $0.63 | $0.28 | $1.32 | $1.10 | Omega Healthcare Investors, Inc. - Balance Sheet Highlights (in thousands) | Balance Sheet Item | Sept 30, 2019 | Dec 31, 2018 | | :--- | :--- | :--- | | **Total Assets** | $8,996,194 | $8,590,877 | | Real estate investments – net | $6,532,446 | $6,183,791 | | **Total Liabilities** | $4,912,732 | $4,826,393 | | Senior notes and other unsecured borrowings – net | $3,822,115 | $3,328,896 | | **Total Equity** | $4,083,462 | $3,764,484 | - Net cash from operating activities for the first nine months of 2019 was **$405.8 million**, up from **$348.5 million** in the prior year, while investing activities provided **$71.5 million** in cash, a significant shift from a use of **$150.6 million** in 2018[25](index=25&type=chunk) [Financial Statements of OHI Healthcare Properties Limited Partnership](index=12&type=section&id=Financial%20Statements%20of%20OHI%20Healthcare%20Properties%20Limited%20Partnership) Presents the financial statements for the operating partnership, which are substantially similar to the parent company's - The financial statements of OHI Healthcare Properties Limited Partnership (Omega OP) are substantially similar to Omega's, with primary differences in the presentation of debt and equity[10](index=10&type=chunk)[26](index=26&type=chunk) OHI Healthcare Properties Limited Partnership - Key Financial Data (in thousands) | Financial Metric | Q3 2019 | Q3 2018 | 9 Months 2019 | 9 Months 2018 | | :--- | :--- | :--- | :--- | :--- | | **Total Operating Revenues** | $233,195 | $221,852 | $682,162 | $661,932 | | **Operating Income** | $187,160 | $110,672 | $435,860 | $381,484 | | **Net Income** | $142,948 | $59,062 | $290,801 | $228,981 | [Notes to Consolidated Financial Statements](index=20&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Highlights significant events including a major merger, adoption of a new lease standard, ongoing litigation, and a subsequent acquisition - On May 17, 2019, Omega completed its **merger with MedEquities Realty Trust, Inc.**, issuing 0.235 shares of Omega common stock and $2.00 in cash for each MedEquities share[43](index=43&type=chunk) - The company adopted the new lease accounting standard, **Topic 842**, on January 1, 2019, resulting in the recognition of right-of-use assets and lease liabilities[80](index=80&type=chunk)[81](index=81&type=chunk) - The company is involved in a **securities class action lawsuit** filed in late 2017; the case was dismissed in March 2019, but plaintiffs have appealed[182](index=182&type=chunk)[183](index=183&type=chunk) - Subsequent to the quarter end, the company completed a **$735 million acquisition of the 60-facility Encore Portfolio** on October 31, 2019[204](index=204&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=47&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Provides management's perspective on financial results, portfolio developments, liquidity, and capital resources for the reporting period [Results of Operations](index=57&type=section&id=Results%20of%20Operations) Analyzes the key drivers of revenue and expense changes for the third quarter and first nine months of 2019 versus 2018 Q3 2019 vs Q3 2018 Performance (in millions) | Metric | Q3 2019 | Q3 2018 | Change | | :--- | :--- | :--- | :--- | | **Operating Revenues** | $233.2 | $221.9 | +$11.3 | | **Operating Expenses** | $99.1 | $105.8 | -$6.7 | | **Nareit FFO** | $163.1 | $160.6 | +$2.5 | - The **$11.3 million increase in Q3 2019 operating revenues** was primarily driven by acquisitions, partially offset by placing certain operators on a cash basis[263](index=263&type=chunk) Nine Months 2019 vs 2018 Performance (in millions) | Metric | 9M 2019 | 9M 2018 | Change | | :--- | :--- | :--- | :--- | | **Operating Revenues** | $682.2 | $661.9 | +$20.2 | | **Operating Expenses** | $299.1 | $289.7 | +$9.4 | | **Nareit FFO** | $464.4 | $462.5 | +$1.9 | - The **$9.4 million increase in operating expenses** for the first nine months of 2019 was mainly due to higher real estate tax expense, depreciation, and merger costs, offset by lower impairment charges[267](index=267&type=chunk) [Portfolio and Recent Developments](index=59&type=section&id=Portfolio%20and%20Recent%20Developments) Details significant portfolio changes including a major merger, asset sales, operator resolutions, and a subsequent large acquisition - Completed the **merger with MedEquities Realty Trust Inc.** on May 17, 2019, acquiring 33 facilities and other investments for approximately **$346 million**[277](index=277&type=chunk) - In Q3 2019, the company **sold 19 facilities for approximately $177.0 million** in net cash proceeds, recognizing a net gain of about **$53.1 million**[293](index=293&type=chunk) - The **Orianna bankruptcy was resolved**, with Omega receiving approximately **$88 million** from the created Distribution Trust through September 30, 2019[300](index=300&type=chunk)[301](index=301&type=chunk) - Operator **Daybreak Venture LLC continues to face liquidity challenges** and did not meet its full contractual payment obligations in Q3 2019[304](index=304&type=chunk)[305](index=305&type=chunk)[307](index=307&type=chunk) - Subsequent to quarter-end, Omega completed the **$735 million acquisition of the 60-facility Encore Portfolio** on October 31, 2019[286](index=286&type=chunk) [Liquidity and Capital Resources](index=64&type=section&id=Liquidity%20and%20Capital%20Resources) Outlines the company's capital structure, recent financing activities, and cash flow generation during the period - As of September 30, 2019, the company had **$9.0 billion in total assets** and **$4.7 billion in total debt**, representing a debt-to-total capitalization ratio of approximately **53.4%**[309](index=309&type=chunk) - On September 20, 2019, the company issued **$500 million of 3.625% Senior Notes due 2029**, with net proceeds of approximately **$487.8 million**[311](index=311&type=chunk) - Entered into a **forward equity sales agreement** on September 9, 2019, to sell **7.5 million shares** of common stock to finance the Encore Portfolio acquisition[313](index=313&type=chunk) - For the nine months ended September 30, 2019, the company generated **$405.8 million in net cash from operating activities**, compared to **$348.5 million** in the prior-year period[321](index=321&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=66&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) Confirms no material changes in the company's market risk exposures or management thereof during the third quarter of 2019 - There were **no material changes** in the company's primary market risk exposures or how those exposures are managed during the quarter ended September 30, 2019[324](index=324&type=chunk) [Controls and Procedures](index=67&type=section&id=Item%204.%20Controls%20and%20Procedures) Asserts the effectiveness of disclosure controls and procedures and notes no material changes to internal controls - Management concluded that the company's **disclosure controls and procedures were effective** as of September 30, 2019[326](index=326&type=chunk) - There were **no changes** during the quarter that materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting[327](index=327&type=chunk) PART II Other Information [Legal Proceedings](index=67&type=section&id=Item%201.%20Legal%20Proceedings) Details ongoing legal matters, including a securities class action lawsuit and a Department of Justice investigation - The company is subject to a **securities class action lawsuit**, which was dismissed but is currently under appeal, and several related shareholder derivative actions[183](index=183&type=chunk)[184](index=184&type=chunk)[185](index=185&type=chunk) - The company is cooperating with a **Department of Justice Civil Investigative Demand (CID)** related to the Lakeway Hospital acquired through the MedEquities merger[193](index=193&type=chunk) [Risk Factors](index=67&type=section&id=Item%201A.%20Risk%20Factors) Updates risk factors related to joint ventures, Brexit, and a forward equity sales agreement - The company identifies risks related to its **joint ventures**, including lack of sole decision-making authority and reliance on partners' financial condition[331](index=331&type=chunk) - The **United Kingdom's withdrawal from the European Union (Brexit)** could adversely affect the company through currency volatility and legal uncertainty[332](index=332&type=chunk)[334](index=334&type=chunk) - The **forward equity sales agreement** could result in substantial dilution to earnings per share and has uncertain tax treatment[337](index=337&type=chunk)[342](index=342&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=71&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) Reports the issuance of common stock in exchange for operating partnership units during the third quarter of 2019 - In Q3 2019, Omega issued **1,248,361 shares of common stock** in exchange for an equal number of Omega OP Units tendered for redemption in an unregistered sale[344](index=344&type=chunk) [Other Information](index=72&type=section&id=Item%205%20Other%20Information) Announces a key executive appointment and a board resolution regarding its classification structure - **Gail D. Makode was appointed** as Omega's Chief Legal Officer and General Counsel, effective November 1, 2019[346](index=346&type=chunk) - In November 2019, the Board adopted a resolution to **opt out of a Maryland law** that permits a classified board structure without stockholder approval[347](index=347&type=chunk) [Exhibits](index=73&type=section&id=Item%206.%20Exhibits) Lists all exhibits filed with the quarterly report, including key agreements and officer certifications - Lists exhibits filed with the report, including the forward equity sales agreement, indenture for the **3.625% Senior Notes due 2029**, and required CEO/CFO certifications[348](index=348&type=chunk)

Omega Healthcare Investors, Inc. (NYSE:OHI) Q3 2019 Earnings Conference Call November 6, 2019 10:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - CEO & Director Robert Stephenson - CFO, Treasurer & Assistant Secretary Daniel Booth - Secretary & COO Steven Insoft - Chief Corporate Development Officer Conference Call Participants Joshua Dennerlein - Bank of America Merrill Lynch Jonathan Hughes - Raymond James & Associates Trent Trujillo - Scotiabank Chad Vanaco ...

[PART I Financial Information](index=5&type=section&id=PART%20I%20Financial%20Information) [Item 1. Financial Statements](index=5&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited consolidated financial statements for Omega Healthcare Investors, Inc. and its operating partnership, including balance sheets, statements of operations, and cash flows, with detailed notes [Financial Statements of Omega Healthcare Investors, Inc.](index=5&type=section&id=Financial%20Statements%20of%20Omega%20Healthcare%20Investors%2C%20Inc.) The consolidated financial statements for Omega Healthcare Investors, Inc. show an increase in total assets to **$9.1 billion** as of June 30, 2019, from **$8.6 billion** at year-end 2018, primarily driven by growth in real estate investments Consolidated Balance Sheet Highlights (in thousands) | Metric | June 30, 2019 | December 31, 2018 | | :--- | :--- | :--- | | Total real estate investments – net | $6,684,102 | $6,183,791 | | Total assets | $9,098,420 | $8,590,877 | | Total liabilities | $5,045,914 | $4,826,393 | | Total stockholders' equity | $3,802,971 | $3,444,441 | Consolidated Statement of Operations Highlights (in thousands, except per share amounts) | Metric | Q2 2019 | Q2 2018 | YTD 2019 | YTD 2018 | | :--- | :--- | :--- | :--- | :--- | | Total operating revenues | $225,279 | $219,881 | $448,967 | $440,080 | | Operating income | $126,525 | $132,677 | $248,700 | $270,812 | | Net income available to common stockholders | $73,141 | $78,536 | $142,843 | $162,756 | | Diluted EPS | $0.34 | $0.39 | $0.68 | $0.82 | Consolidated Statement of Cash Flows Highlights - Six Months Ended June 30 (in thousands) | Metric | 2019 | 2018 | | :--- | :--- | :--- | | Net cash provided by operating activities | $265,412 | $217,166 | | Net cash used in investing activities | ($15,012) | ($6,250) | | Net cash used in financing activities | ($227,764) | ($294,056) | | Increase (decrease) in cash | $22,467 | ($83,259) | [Financial Statements of OHI Healthcare Properties Limited Partnership](index=14&type=section&id=Financial%20Statements%20of%20OHI%20Healthcare%20Properties%20Limited%20Partnership) The financial statements for OHI Healthcare Properties Limited Partnership mirror those of the parent company, Omega, in terms of assets and operating results, with primary differences in liabilities and equity presentation - Omega OP's total assets of **$9.1 billion** as of June 30, 2019, are identical to the parent company's consolidated assets[28](index=28&type=chunk) - A significant liability on Omega OP's balance sheet is the **$4.7 billion** in intercompany loans payable to the parent, Omega, as of June 30, 2019[28](index=28&type=chunk) - Net income for Omega OP was **$75.7 million** for Q2 2019 and **$147.9 million** for the six months ended June 30, 2019, identical to the consolidated net income of the parent company before noncontrolling interest adjustments[31](index=31&type=chunk) [Notes to Consolidated Financial Statements](index=21&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) These notes detail the company's accounting policies, significant events including the MedEquities merger and lease accounting standard adoption, operator developments, and subsequent events like a major acquisition agreement - On May 17, 2019, Omega completed its merger with MedEquities Realty Trust, Inc., acquiring it for consideration valued at approximately **$346 million**, consisting of stock and cash[43](index=43&type=chunk)[100](index=100&type=chunk) - The company adopted the new lease accounting standard, **Topic 842**, on **January 1, 2019**, using the modified retrospective method, resulting in the recognition of right-of-use assets and lease liabilities[78](index=78&type=chunk) - Following the resolution of the Orianna bankruptcy in January 2019, the company received approximately **$88 million** from the created Distribution Trust and recorded a **$7.7 million** allowance in Q1 2019 due to diminished collectability of remaining receivables[113](index=113&type=chunk)[114](index=114&type=chunk)[115](index=115&type=chunk) - On July 26, 2019, the company entered into an agreement to purchase **60 facilities** for **$735 million**, consisting of cash and the assumption of approximately **$390 million** in HUD-guaranteed mortgage loans[192](index=192&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=73&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial performance, revenue drivers, the regulated healthcare environment, operator updates, and confirms sufficient liquidity for future operations and investments - The company's core business is providing financing and capital to the long-term healthcare industry, with a portfolio of **949 facilities** in 41 states and the U.K. as of June 30, 2019[197](index=197&type=chunk)[201](index=201&type=chunk) - The healthcare industry is heavily regulated, with significant operator revenue derived from Medicare and Medicaid, noting the shift to the value-based **Patient Driven Payment Model (PDPM)** effective **October 1, 2019**, which could materially affect operators' financial conditions[208](index=208&type=chunk)[213](index=213&type=chunk)[218](index=218&type=chunk) - **Daybreak Venture LLC** remains on a cash basis for revenue recognition due to liquidity challenges stemming from low occupancy, high labor costs, and a low Texas Medicaid rate, leading to reduced expectations for future quarterly cash rent receipts[287](index=287&type=chunk)[288](index=288&type=chunk)[289](index=289&type=chunk) - Management believes its liquidity, including cash from operations and availability under its credit facilities, is **adequate liquidity** to finance operations, meet debt service, and fund future investments through the next twelve months[300](index=300&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=105&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company states that there were no material changes in its primary market risk exposures or the management of those exposures during the quarter ended June 30, 2019 - There were **no material changes** in the company's primary market risk exposures during Q2 2019[306](index=306&type=chunk) [Controls and Procedures](index=105&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of June 30, 2019, with no material changes to internal control over financial reporting identified during the quarter - The CEO and CFO concluded that the company's disclosure controls and procedures were **effective** as of June 30, 2019[308](index=308&type=chunk) - **No material changes** to the company's internal control over financial reporting were identified during the quarter[309](index=309&type=chunk) [PART II Other Information](index=107&type=section&id=PART%20II%20Other%20Information) [Legal Proceedings](index=107&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in various legal proceedings, including a securities class action, merger-related lawsuits, and a Department of Justice investigation, which management intends to vigorously defend - A securities class action lawsuit alleging misleading statements was **dismissed with prejudice** in March 2019, but the plaintiffs filed an appeal in April 2019[173](index=173&type=chunk) - **Four separate lawsuits** were filed by MedEquities stockholders challenging the merger with Omega; two of these lawsuits also name Omega as a defendant[176](index=176&type=chunk) - The company is cooperating with a **U.S. Department of Justice (DOJ) investigation** regarding alleged violations related to Lakeway Hospital, an asset in which Omega now holds a **51% interest**[182](index=182&type=chunk)[183](index=183&type=chunk) [Risk Factors](index=107&type=section&id=Item%201A.%20Risk%20Factors) This section highlights additional or revised risk factors, including those related to joint ventures and the potential adverse impacts of Brexit on the company's operations and investments - The company highlights **risks associated with joint ventures**, including the inability to take actions opposed by partners, reliance on partners' financial condition, and potential for disputes[313](index=313&type=chunk)[315](index=315&type=chunk) - The withdrawal of the U.K. from the E.U. (**Brexit**) is identified as a risk that could adversely affect the company through **currency volatility**, legal uncertainty, and potential changes to tax and trade laws[314](index=314&type=chunk)[317](index=317&type=chunk)[319](index=319&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=109&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) During the second quarter of 2019, Omega issued 251,679 shares of its common stock in exchange for an equal number of Omega OP Units that were tendered for redemption in a private transaction - In Q2 2019, the company issued **251,679 unregistered shares** of common stock to redeem an equivalent number of Omega OP Units[321](index=321&type=chunk) [Other Information](index=110&type=section&id=Item%205.%20Other%20Information) A new retirement policy for executive officers was adopted, effective January 1, 2020, providing for prorated and full vesting of equity incentives under specific eligibility and notice conditions - A **new retirement policy** was adopted on August 2, 2019, for executive officers, effective for grants made on or after **January 1, 2020**[322](index=322&type=chunk) - To be eligible, an officer must be at least **62 years old with 10 years of service** and provide at least **6 months' notice** of retirement[322](index=322&type=chunk) - The policy provides for **prorated vesting** of performance-based equity and **full vesting** of time-based equity for qualifying retirees[322](index=322&type=chunk)[323](index=323&type=chunk) [Exhibits](index=111&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including employment agreement amendments, CEO and CFO certifications, and XBRL interactive data files

Supplemental Information Q2 2019 Omega Healthcare Investors, Inc. is a Real Estate Investment Trust ("REIT") providing financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities located in the United States, and to a lesser extent the United Kingdom. As of June 30, 2019, Omega has a portfolio of investments that includes over 930 properties located in 41 states (includes the New York City Carnegie Hill project) and the UK (55 facilities) and operated by ...

Omega Healthcare Investors, Inc. (NYSE:OHI) Q2 2019 Earnings Conference Call August 7, 2019 11:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - CEO & Director Robert Stephenson - CFO, Treasurer & Assistant Secretary Daniel Booth - Secretary & COO Jeff Marshall - SVP, Operations Steven Insoft - Chief Corporate Development Officer Conference Call Participants Karin Ford - MUFG Securities Jonathan Hughes - Raymond James & Associates Lukas Hartwich - Green Street ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP (Exact name of registrant as specified in its charter) (OH ...

Omega Healthcare Investors, Inc. (NYSE:OHI) Q1 2019 Earnings Conference Call May 8, 2019 10:00 AM ET Company Participants Michele Reber - Investor Relations Taylor Pickett - Chief Executive Officer Robert Stephenson - Chief Financial Officer Daniel Booth - Chief Operating Officer Jeff Marshall - Senior Vice President, Operations Steven Insoft - Chief Corporate Development Officer Conference Call Participants Jonathan Hughes - Raymond James Karin Ford - MUFG Securities Trent Trujillo - Scotiabank Chad Vanaco ...

Part I [Business](index=4&type=section&id=Item%201.%20Business) Omega Healthcare Investors is a REIT financing the long-term healthcare industry via triple-net leases and mortgages for SNFs and ALFs in the U.S. and U.K [Overview; Recent Events](index=4&type=section&id=Overview%3B%20Recent%20Events) Omega operates as a REIT providing capital to the long-term healthcare industry, completed approximately $471 million in new investments in 2018, and agreed to acquire MedEquities Realty Trust for about $600 million in January 2019 - Omega's core business is providing financing and capital to the long-term healthcare industry, focusing on **Skilled Nursing Facilities (SNFs)** and **Assisted Living Facilities (ALFs)** through triple-net leases and mortgage agreements[24](index=24&type=chunk) - As of December 31, 2018, the company's portfolio consisted of **924 healthcare facilities** in 41 states and the U.K., operated by 68 third-party operators, with a total investment value of approximately **$8.6 billion**[27](index=27&type=chunk) - On January 2, 2019, Omega entered into an agreement to acquire MedEquities Realty Trust, Inc for total consideration of approximately **$600 million**, including assumed debt[28](index=28&type=chunk) 2018 New Investments Summary | Investment Type | Amount (millions) | Description | | :--- | :--- | :--- | | Secured Term Loan | $131.3 | Secured by 11 facilities in PA & VA, interest rate of 9.35% | | First Mortgage Loan | $44.2 | Secured by 5 SNFs in MI, initial interest rate of 9.5% | | New Investments (Acquisition) | $35.1 | Acquisition of 3 SNFs and 1 ILF in PA, initial cash yield of 9.5% | | New Investments (U.K.) | $9.1 | Acquisition of 2 care homes in the U.K., initial cash yield of 8.5% | | Other Acquisitions & Investments | $70.7 | Acquired 9 SNFs and 1 ALF for $60.7M and invested $10.0M in a mezzanine loan | | Capital Expenditure Programs | $180.9 | Investments in capital improvement programs | | **Total** | **$471.3** | | [Summary of Financial Information by Asset Category](index=5&type=section&id=Summary%20of%20Financial%20Information%20by%20Asset%20Category) This section breaks down revenues and assets by category from 2016 to 2018, showing a slight revenue decline in 2018 while total investments remained stable at approximately $9.1 billion Revenues by Asset Category (in thousands) | Category | 2018 | 2017 | 2016 | | :--- | :--- | :--- | :--- | | Rental income | $767,340 | $775,176 | $743,885 | | Income from direct financing leases | $1,636 | $32,336 | $62,298 | | Mortgage interest income | $70,312 | $66,202 | $69,811 | | **Total core assets revenues** | **$839,288** | **$873,714** | **$875,994** | | Other investment income | $40,228 | $29,225 | $21,852 | | Miscellaneous income | $2,166 | $5,446 | $2,981 | | **Total operating revenues** | **$881,682** | **$908,385** | **$900,827** | Assets by Category (in thousands) | Category | As of Dec 31, 2018 | As of Dec 31, 2017 | | :--- | :--- | :--- | | Total real estate investments | $7,746,410 | $7,655,960 | | Investments in direct financing leases - net | $132,262 | $364,965 | | Mortgage notes receivable - net | $710,858 | $671,232 | | **Total core assets** | **$8,589,530** | **$8,692,157** | | Other investments - net | $504,626 | $276,342 | | Investment in unconsolidated joint venture | $31,045 | $36,516 | | Assets held for sale - net | $989 | $86,699 | | **Total investments** | **$9,126,190** | **$9,091,714** | [Description of the Business](index=6&type=section&id=Description%20of%20the%20Business) The company's strategy focuses on a diverse portfolio of healthcare facilities operated by creditworthy operators, structured as triple-net leases and fixed-rate mortgages, while facing industry competition - The company's investment criteria include the operator's quality and creditworthiness, facility cash flow, physical condition, location, and the regulatory and reimbursement environment[34](index=34&type=chunk)[36](index=36&type=chunk) - Competition in the healthcare industry is high, coming from other REITs, private equity, hedge funds, and other institutional investors, some with greater resources and lower capital costs[44](index=44&type=chunk) Primary Investment Structures and Yields (as of Dec 31, 2018) | Investment Structure | Typical Term | Average Annualized Yield | | :--- | :--- | :--- | | Triple-Net Operating Leases | 5 to 15 years | ~9.2% | | Direct Financing Leases | N/A | ~9.0% | | Fixed-Rate Mortgages | N/A | ~10.1% | [Taxation of Omega](index=9&type=section&id=Taxation%20of%20Omega) This section details Omega's tax structure as a REIT, outlining the requirements to maintain this status, including income tests, asset tests, and distribution mandates - To maintain its REIT qualification, Omega must annually satisfy two gross income tests: at least **75% of gross income** must come from real property investments, and at least **95%** must be from such investments plus other passive sources[52](index=52&type=chunk) - The company must satisfy several asset tests at the end of each quarter, including that at least **75% of total assets** are real estate assets, cash, or government securities[68](index=68&type=chunk) - A critical requirement for REIT status is the annual distribution of at least **90% of its "REIT taxable income"** to stockholders[75](index=75&type=chunk)[76](index=76&type=chunk) - If Omega fails to qualify as a REIT, it would be subject to **federal income tax at regular corporate rates** and would be disqualified from REIT status for the following four taxable years[80](index=80&type=chunk) [Government Regulation and Reimbursement](index=23&type=section&id=Government%20Regulation%20and%20Reimbursement) The healthcare industry and Omega's operators are subject to extensive regulations, with significant revenue reliance on Medicare and Medicaid, making them vulnerable to reimbursement changes - A significant portion of the revenue for Omega's operators is derived from government-funded programs like **Medicare and Medicaid**, making them susceptible to reimbursement reductions[100](index=100&type=chunk) - CMS issued a final rule for FY 2019 that replaces the SNF PPS RUG-IV payment model with a new value-based **Patient Driven Payment Model (PDPM)**, effective October 1, 2019[104](index=104&type=chunk) - The **Office of Inspector General (OIG)** and the **Department of Justice (DOJ)** have increased scrutiny on SNFs, focusing on quality of care, staffing levels, and billing practices[111](index=111&type=chunk)[113](index=113&type=chunk) - Operators are subject to strict fraud and abuse laws, including the **Anti-kickback Statute** and **Stark Law**, violations of which can lead to severe sanctions[116](index=116&type=chunk)[117](index=117&type=chunk) [Executive Officers of Our Company](index=31&type=section&id=Executive%20Officers%20of%20Our%20Company) This section provides biographical details for the company's five key executive officers as of February 1, 2019 - **C. Taylor Pickett** has served as Chief Executive Officer since June 2001 and as a Director since May 2002[127](index=127&type=chunk) - The executive team consists of **C. Taylor Pickett (CEO)**, **Daniel J. Booth (COO)**, **Steven J. Insoft (Chief Corporate Development Officer)**, **Robert O. Stephenson (CFO)**, and **Michael D. Ritz (Chief Accounting Officer)**[127](index=127&type=chunk)[128](index=128&type=chunk)[129](index=129&type=chunk)[130](index=130&type=chunk)[131](index=131&type=chunk) [Risk Factors](index=31&type=section&id=Item%201A.%20Risk%20Factors) This section outlines significant risks affecting the company, categorized into operator-related, operational, taxation, stock-related, and acquisition-specific risks [Risks Related to the Operators of Our Facilities](index=31&type=section&id=Risks%20Related%20to%20the%20Operators%20of%20Our%20Facilities) The company's stability depends on its operators' ability to meet obligations, facing risks from operator bankruptcy, extensive government regulation, and reliance on Medicare/Medicaid reimbursement - The **bankruptcy or insolvency of operators** poses a significant risk, as it could limit or delay the company's ability to collect unpaid rent and mortgage payments[136](index=136&type=chunk)[137](index=137&type=chunk) - Operators' revenues are highly dependent on government reimbursement programs like **Medicare and Medicaid**, and funding reductions could materially harm their financial condition[143](index=143&type=chunk)[148](index=148&type=chunk)[150](index=150&type=chunk) - Failure by operators to comply with numerous federal, state, and local regulations could result in fines, penalties, or exclusion from reimbursement programs, jeopardizing their ability to make payments[142](index=142&type=chunk)[143](index=143&type=chunk)[145](index=145&type=chunk) [Risks Related to Us and Our Operations](index=42&type=section&id=Risks%20Related%20to%20Us%20and%20Our%20Operations) Omega faces operational risks including reliance on external capital, debt covenants, interest rate fluctuations, potential asset impairments, and international investment uncertainties like Brexit - Due to the REIT distribution requirement of at least **90% of taxable income**, the company relies on external debt and equity financing for future capital needs[162](index=162&type=chunk) - Covenants in debt agreements limit operational flexibility, and a breach could lead to default, while the planned **phase-out of LIBOR** creates uncertainty for variable-rate debt[173](index=173&type=chunk)[168](index=168&type=chunk) - The company's investments in the U.K. subject it to risks from **currency exchange rate fluctuations** and the economic and legal uncertainty surrounding **Brexit**[182](index=182&type=chunk)[184](index=184&type=chunk)[186](index=186&type=chunk) - The company has significant investment concentrations in **Florida (10%)**, **Texas (10%)**, and **Michigan (8%)**, exposing it to adverse conditions in those states[185](index=185&type=chunk) [Risks Related to Taxation](index=52&type=section&id=Risks%20Related%20to%20Taxation) This section highlights the critical risk of failing to maintain REIT status, which would subject the company to corporate income tax and significantly reduce cash flow - **Failure to maintain qualification as a REIT** would subject the company to federal income tax at regular corporate rates, significantly reducing net earnings and cash available for distribution[195](index=195&type=chunk)[196](index=196&type=chunk) - Complying with REIT requirements may force the company to **liquidate otherwise attractive investments** or make distributions at disadvantageous times to meet income, asset, and distribution tests[200](index=200&type=chunk) - The **Tax Cuts and Jobs Act of 2017** introduced broad changes that could impact the computation of the company's taxable income and required distributions[201](index=201&type=chunk)[202](index=202&type=chunk) [Risks Related to Our Stock](index=56&type=section&id=Risks%20Related%20to%20Our%20Stock) The market value of Omega's common stock is subject to volatility, potential dilution from future equity or debt issuances, and the uncertainty of future dividend payments - The market price of the company's stock is subject to volatility and can be affected by factors such as **market perception of REITs**, analyst reports, and interest rates[207](index=207&type=chunk) - Future sales of capital stock or convertible debt could **dilute the ownership interests** of existing stockholders and negatively impact the market price of the common stock[207](index=207&type=chunk)[211](index=211&type=chunk) - There is **no assurance of the company's ability to pay dividends** in the future, as payments depend on earnings, financial condition, and maintaining REIT status[213](index=213&type=chunk) [Risks Related to our Proposed Acquisition of MedEquities](index=58&type=section&id=Risks%20Related%20to%20our%20Proposed%20Acquisition%20of%20MedEquities) The pending acquisition of MedEquities presents risks including potential non-completion, integration challenges, failure to realize synergies, and possible adverse tax consequences - The consummation of the merger with MedEquities is subject to a number of conditions, and there is **no assurance that the merger will be completed**[216](index=216&type=chunk)[217](index=217&type=chunk) - The company may be unable to successfully integrate the MedEquities business or **realize the anticipated synergies**, which could result in the merger not being accretive to earnings[219](index=219&type=chunk)[225](index=225&type=chunk) - Omega may incur adverse tax consequences if **MedEquities has failed to qualify as a REIT** for U.S. federal income tax purposes[228](index=228&type=chunk) [Unresolved Staff Comments](index=60&type=section&id=Item%201B.%20Unresolved%20Staff%20Comments) The company reports that there are no unresolved staff comments from the SEC - None[229](index=229&type=chunk) [Properties](index=61&type=section&id=Item%202.%20Properties) As of year-end 2018, Omega's portfolio included 924 properties across 41 states and the U.K., with geographic concentrations in Florida, Texas, and Michigan - The portfolio is operated by 68 different healthcare providers, with the **top five operators representing approximately 38%** of the total portfolio by investment[237](index=237&type=chunk) Top 5 State Concentrations by Gross Real Estate Investment (as of Dec 31, 2018) | Location | % of Gross Real Estate Investment | | :--- | :--- | | Florida | 9.75% | | Texas | 9.62% | | Michigan | 8.02% | | Ohio | 6.90% | | Indiana | 6.88% | Operating Lease Expiration Schedule (Annualized Straight-line Rental Revenue) | Expiration Year | Revenue Expiring ($ in thousands) | | :--- | :--- | | 2019 | $2,174 | | 2020 | $4,039 | | 2021 | $4,940 | | 2022 | $36,756 | | 2023 | $13,667 | | Thereafter | $510,996 | [Legal Proceedings](index=64&type=section&id=Item%203.%20Legal%20Proceedings) The company faces a consolidated securities class action lawsuit alleging false or misleading statements regarding an operator's financial condition, which it intends to defend vigorously - A **securities class action lawsuit** was filed against the company and certain officers in November 2017, alleging violations of the Securities Exchange Act of 1934[240](index=240&type=chunk)[242](index=242&type=chunk) - The lawsuit claims the company made misleading statements and failed to disclose adverse facts about an **operator's financial health** and its ability to pay rent[242](index=242&type=chunk) - A related **shareholder derivative action** was filed in August 2018, which has been stayed pending the resolution of the securities class action[245](index=245&type=chunk) [Mine Safety Disclosures](index=65&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) The company reports that there are no mine safety disclosures applicable to its operations - None[247](index=247&type=chunk) Part II [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=66&type=section&id=Item%205.%20Market%20for%20the%20Registrant's%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) This section provides details on Omega's common stock (NYSE: OHI), including shareholder count, equity compensation plans, and a report of no equity repurchases in Q4 2018 - Omega's common stock is traded on the New York Stock Exchange under the symbol **"OHI"** with **204,229,335 shares outstanding** as of February 19, 2019[249](index=249&type=chunk) - The company **did not purchase any of its outstanding equity securities** during the fourth quarter of 2018[252](index=252&type=chunk) Equity Compensation Plan Information (as of Dec 31, 2018) | Plan Category | Securities to be issued upon exercise | Weighted-average exercise price | Securities remaining available for future issuance | | :--- | :--- | :--- | :--- | | Approved by security holders | 3,011,181 | $— | 5,085,092 | | Not approved by security holders | — | $— | — | | **Total** | **3,011,181** | **$—** | **5,085,092** | [Selected Financial Data](index=68&type=section&id=Item%206.%20Selected%20Financial%20Data) This section presents a five-year summary of selected historical financial and operating data for Omega and its operating partnership from 2014 to 2018 Omega Selected Financial Data (2016-2018, in thousands) | Metric | 2018 | 2017 | 2016 | | :--- | :--- | :--- | :--- | | **Operating Data** | | | | | Revenues | $881,682 | $908,385 | $900,827 | | Net income | $293,884 | $104,910 | $383,367 | | Diluted EPS | $1.40 | $0.51 | $1.90 | | Dividends per Share | $2.64 | $2.54 | $2.36 | | **Balance Sheet Data (Year-End)** | | | | | Gross investments | $9,126,190 | $9,091,714 | $9,166,129 | | Total assets | $8,590,877 | $8,773,305 | $8,949,260 | | Total equity | $3,764,484 | $3,888,258 | $4,211,986 | [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=70&type=section&id=Item%207.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This MD&A provides management's perspective on financial condition and results, covering the business outlook, 2018 highlights, portfolio changes, and an analysis of operating results [Overview and Outlook](index=70&type=section&id=Overview%20and%20Outlook) Management notes stable portfolio occupancy despite industry declines, but operators face challenges from labor costs and managed care, with a positive long-term outlook driven by demographics and PDPM - Operators are experiencing **increased labor costs** and declines in their quality payor mix, driven by managed care pressure on lengths of stay and rates[271](index=271&type=chunk) - The **Texas operating environment is challenging** for SNF operators due to low statewide occupancy and low Medicaid reimbursement rates[271](index=271&type=chunk) - Management believes operators will generally benefit from the October 2019 change in the Medicare payment system to the **Patient Driven Payment Model (PDPM)** and from projected growth in elderly demographics[273](index=273&type=chunk) [2018 and Recent Highlights](index=72&type=section&id=2018%20and%20Recent%20Highlights) In 2018, Omega completed new investments totaling approximately $471 million and agreed in January 2019 to acquire MedEquities Realty Trust for about $600 million - The company completed approximately **$471 million in new investments** during 2018, including loans, acquisitions in the U.S. and U.K., and capital expenditure programs[275](index=275&type=chunk)[277](index=277&type=chunk) - On January 2, 2019, Omega agreed to acquire MedEquities Realty Trust, Inc for approximately **$600 million** in a stock and cash transaction, including assumed debt[276](index=276&type=chunk) [Portfolio and Other Developments](index=73&type=section&id=Portfolio%20and%20Other%20Developments) This section details a slowdown in acquisition activity from 2016 to 2018, with a notable 2018 transaction involving the transition of 22 facilities to new operating leases - In 2018, the company transitioned **22 facilities** with a net carrying value of $184.5 million from a direct financing lease with one operator to new operating leases with five existing operators[282](index=282&type=chunk) Acquisition Summary (2016-2018) | Year | Number of Facilities Acquired | Total Investment (in millions) | | :--- | :--- | :--- | | 2018 | 15 | $105.7 | | 2017 | 51 | $412.7 | | 2016 | 90 | $1,022.8 | [Asset Sales, Impairments, Accounts Receivable and Other](index=75&type=section&id=Asset%20Sales%2C%20Impairments%2C%20Accounts%20Receivable%20and%20Other) This section details significant portfolio restructuring, including asset sales, impairments, and challenges with operators like Orianna, Signature Healthcare, and Daybreak Venture - **Orianna Health Systems** filed for Chapter 11 bankruptcy in March 2018, and Omega managed the transition and sale of its facilities, a process concluded in early 2019[308](index=308&type=chunk)[311](index=311&type=chunk)[313](index=313&type=chunk) - In May 2018, Omega completed a consensual, out-of-court restructuring with **Signature Healthcare**, which involved creating a new holding company (Agemo), deferring rent, and providing a new working capital loan[318](index=318&type=chunk) - **Daybreak Venture**, an operator primarily in Texas, was placed on a cash basis for revenue recognition in 2017 and received further rent deferrals in late 2018 and early 2019[320](index=320&type=chunk)[321](index=321&type=chunk) Asset Sales and Impairments (2017-2018) | Metric | 2018 | 2017 | | :--- | :--- | :--- | | Facilities Sold | 78 | 52 | | Net Proceeds from Sales | ~$309.6M | ~$257.8M | | Gain on Sale | ~$24.8M | ~$53.9M | | Impairments on Real Estate | ~$35.0M | ~$99.1M | | Impairments on Direct Financing Leases | ~$27.2M | ~$198.2M | [Results of Operations](index=82&type=section&id=Results%20of%20Operations) This section analyzes operating results, noting that while 2018 revenue decreased, net income rose significantly due to substantially lower impairment charges compared to 2017 - The decrease in 2018 revenue was primarily due to a **$30.7 million drop in direct financing lease income**, largely from placing operator Orianna on a cash basis[325](index=325&type=chunk) - The significant increase in 2018 net income was mainly due to a large reduction in impairment charges, which fell from **$198.2 million in 2017 to $27.2 million in 2018**[326](index=326&type=chunk) Comparison of Operations (in millions) | Metric | 2018 | 2017 | 2016 | | :--- | :--- | :--- | :--- | | Total Operating Revenues | $881.7 | $908.4 | $900.8 | | Total Operating Expenses | $408.9 | $647.1 | $391.1 | | Impairment (Real Estate & DFL) | $57.0 | $297.3 | $58.7 | | Net Income | $293.9 | $104.9 | $383.4 | | Nareit FFO | $587.4 | $444.3 | $660.1 | [Liquidity and Capital Resources](index=87&type=section&id=Liquidity%20and%20Capital%20Resources) As of year-end 2018, the company had $8.6 billion in assets and $4.6 billion in debt, with liquidity from operations, credit facilities, and asset sales deemed adequate for the next year - Net cash provided by operating activities **decreased by $78.5 million to $499.4 million** in 2018, primarily due to lost income from Orianna and a $50.0 million payment to an operator[357](index=357&type=chunk) - In 2018, the company issued approximately 2.3 million shares under its Equity Shelf Program, generating **net proceeds of $75.5 million**[350](index=350&type=chunk) - The company paid total dividends of **$528.7 million** to its common stockholders in 2018, at a rate of $0.66 per share per quarter[352](index=352&type=chunk)[353](index=353&type=chunk) Contractual Obligations as of Dec 31, 2018 (in thousands) | Obligation | Total | Less than 1 year | Years 2-3 | Years 4-5 | More than 5 years | | :--- | :--- | :--- | :--- | :--- | :--- | | Debt | $4,585,990 | $— | $333,000 | $1,602,990 | $2,650,000 | | Interest payments on long-term debt | $1,272,957 | $203,960 | $402,181 | $336,416 | $330,400 | [Critical Accounting Policies and Estimates](index=90&type=section&id=Critical%20Accounting%20Policies%20and%20Estimates) Management identifies four critical accounting policies requiring significant judgment: Lease Accounting, Revenue Recognition, Investment Impairment, and Allowance for Losses on Mortgages and Investments - The four critical accounting policies identified are: **Lease Accounting**, **Revenue Recognition and Allowance for Doubtful Accounts**, **Depreciation and Real Estate Investment Impairment**, and **Allowance for Losses on Mortgages, Other Investments and Direct Financing Leases**[361](index=361&type=chunk) - The company evaluates real estate investments for impairment when indicators are present by comparing the carrying value to future undiscounted cash flows, a process involving **significant management estimation**[374](index=374&type=chunk) - Allowances for losses on loans and receivables are based on quarterly evaluations of collectability, considering factors like delinquency and borrower financial strength, which requires **significant judgment**[371](index=371&type=chunk)[376](index=376&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=93&type=section&id=Item%207A.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company is primarily exposed to interest rate risk, which it mitigates by matching investment terms with long-term, fixed-rate borrowings and using derivative instruments for hedging - The company's primary market risk is from **changes in interest rates**, which affect the fair value of its fixed-rate debt and mortgages[378](index=378&type=chunk) - A hypothetical **one percent increase in interest rates** would result in an estimated decrease of **$227.2 million** in the fair value of the company's long-term borrowings as of December 31, 2018[384](index=384&type=chunk) - The company uses **interest rate swap agreements** to hedge interest rate risk, such as converting a variable-rate term loan to an effective fixed rate of 3.8005%[385](index=385&type=chunk) [Financial Statements and Supplementary Data](index=94&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) This item incorporates by reference the company's consolidated financial statements and the independent auditor's report, which are filed beginning on page F-1 - The consolidated financial statements and the report of Ernst & Young LLP, Independent Registered Public Accounting Firm, are filed beginning on page F-1 of the report[386](index=386&type=chunk) [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](index=94&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20with%20Accountants%20on%20Accounting%20and%20Financial%20Disclosure) The company reports that there have been no changes in or disagreements with its accountants on accounting and financial disclosure - None[387](index=387&type=chunk) [Controls and Procedures](index=94&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures, as well as its internal control over financial reporting, were effective as of December 31, 2018 - The Chief Executive Officer and Chief Financial Officer concluded that the company's **disclosure controls and procedures were effective** as of December 31, 2018[389](index=389&type=chunk) - Management assessed the effectiveness of internal control over financial reporting and concluded that it was **effective as of December 31, 2018**, based on the COSO framework[392](index=392&type=chunk) [Other Information](index=96&type=section&id=Item%209B.%20Other%20Information) The company reports that there is no other information to disclose under this item - None[395](index=395&type=chunk) Part III [Directors, Executive Officers of the Registrant and Corporate Governance](index=97&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20of%20the%20Registrant%20and%20Corporate%20Governance) Information on directors and corporate governance is incorporated by reference from the 2019 proxy statement, while executive officer information is provided in Part I of this report - Information required by this item is **incorporated by reference** from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders[398](index=398&type=chunk) [Executive Compensation](index=97&type=section&id=Item%2011.%20Executive%20Compensation) Information regarding executive compensation is incorporated by reference from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders - Information required by this item is **incorporated by reference** from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders[400](index=400&type=chunk) [Security Ownership of Certain Beneficial Owners and Management](index=97&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management) Information regarding security ownership is incorporated by reference from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders - Information required by this item is **incorporated by reference** from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders[401](index=401&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=97&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) Information regarding related party transactions and director independence is incorporated by reference from the company's 2019 proxy statement - Information required by this item is **incorporated by reference** from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders[402](index=402&type=chunk) [Principal Accountant Fees and Services](index=97&type=section&id=Item%2014.%20Principal%20Accountant%20Fees%20and%20Services) Information regarding principal accountant fees and services is incorporated by reference from the company's 2019 proxy statement - Information required by this item is **incorporated by reference** from the company's definitive proxy statement for the 2019 Annual Meeting of Stockholders[403](index=403&type=chunk) Part IV [Exhibits and Financial Statement Schedules](index=98&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section lists the consolidated financial statements, financial statement schedules, and all exhibits filed as part of the Form 10-K report - This item lists the consolidated financial statements, schedules (Schedule II, Schedule III, Schedule IV), and exhibits included with the filing[406](index=406&type=chunk)[407](index=407&type=chunk) [Form 10-K Summary](index=99&type=section&id=Item%2016.%20Summary) The company has elected not to include a summary of the information required by Form 10-K under this optional item - The company has elected not to include summary information under this item[408](index=408&type=chunk) Financial Statements [Report of Independent Registered Public Accounting Firm](index=100&type=section&id=Report%20of%20Independent%20Registered%20Public%20Accounting%20Firm) Ernst & Young LLP issued unqualified opinions on the financial statements and internal controls for both Omega and its operating partnership as of December 31, 2018 - Ernst & Young, LLP provided an **unqualified opinion** on the consolidated financial statements for both Omega and Omega OP for the three years ended December 31, 2018[411](index=411&type=chunk)[425](index=425&type=chunk) - The auditor also issued an **unqualified opinion** on the effectiveness of each company's internal control over financial reporting as of December 31, 2018[412](index=412&type=chunk)[426](index=426&type=chunk) [Consolidated Financial Statements](index=105&type=section&id=Consolidated%20Financial%20Statements) This section contains the primary consolidated financial statements for Omega and its operating partnership for the years ended December 31, 2018, 2017, and 2016 Omega Healthcare Investors, Inc. - Key Financials (in thousands) | Metric | 2018 | 2017 | | :--- | :--- | :--- | | **Balance Sheet** | | | | Total Assets | $8,590,877 | $8,773,305 | | Total Liabilities | $4,826,393 | $4,885,047 | | Total Equity | $3,764,484 | $3,888,258 | | **Income Statement** | | | | Total Operating Revenues | $881,682 | $908,385 | | Net Income | $293,884 | $104,910 | [Notes to Consolidated Financial Statements](index=115&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) The notes provide detailed disclosures supplementing the financial statements, covering accounting policies, asset breakdowns, debt arrangements, and subsequent events like the MedEquities merger